These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

199 related items for PubMed ID: 32168196

  • 1. Utilization of imaging for staging in bladder cancer: is there a role for MRI or PET-computed tomography?
    Cipollari S, Carnicelli G, Bicchetti M, Campa R, Pecoraro M, Panebianco V.
    Curr Opin Urol; 2020 May; 30(3):377-386. PubMed ID: 32168196
    [Abstract] [Full Text] [Related]

  • 2. Evaluating the impact of 18F-FDG-PET-CT on risk stratification and treatment adaptation for patients with muscle-invasive bladder cancer (EFFORT-MIBC): a phase II prospective trial.
    Verghote F, Poppe L, Verbeke S, Dirix P, Albersen M, De Meerleer G, Berghen C, Ost P, Villeirs G, De Visschere P, De Man K, De Maeseneer D, Rottey S, Van Praet C, Decaestecker K, Fonteyne V.
    BMC Cancer; 2021 Oct 18; 21(1):1113. PubMed ID: 34663254
    [Abstract] [Full Text] [Related]

  • 3. Imaging muscle-invasive and metastatic urothelial carcinoma.
    Malayeri AA, Pattanayak P, Apolo AB.
    Curr Opin Urol; 2015 Sep 18; 25(5):441-8. PubMed ID: 26222929
    [Abstract] [Full Text] [Related]

  • 4. Value of multiparametric magnetic resonance imaging for local staging of invasive urinary bladder tumours.
    Huele EH, Veenboer PW, Wessels FJ, Jonges TN, Meijer RP.
    Urol Oncol; 2023 Jan 18; 41(1):49.e7-49.e12. PubMed ID: 36441069
    [Abstract] [Full Text] [Related]

  • 5. An evaluation of morphological and functional multi-parametric MRI sequences in classifying non-muscle and muscle invasive bladder cancer.
    Panebianco V, De Berardinis E, Barchetti G, Simone G, Leonardo C, Grompone MD, Del Monte M, Carano D, Gallucci M, Catto J, Catalano C.
    Eur Radiol; 2017 Sep 18; 27(9):3759-3766. PubMed ID: 28181054
    [Abstract] [Full Text] [Related]

  • 6. 18F-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography in muscle-invasive bladder cancer.
    Einerhand SMH, van Gennep EJ, Mertens LS, Hendricksen K, Donswijk ML, van der Poel HG, van Rhijn BWG.
    Curr Opin Urol; 2020 Sep 18; 30(5):654-664. PubMed ID: 32701719
    [Abstract] [Full Text] [Related]

  • 7. Multiparametric MRI of the bladder: inter-observer agreement and accuracy with the Vesical Imaging-Reporting and Data System (VI-RADS) at a single reference center.
    Barchetti G, Simone G, Ceravolo I, Salvo V, Campa R, Del Giudice F, De Berardinis E, Buccilli D, Catalano C, Gallucci M, Catto JWF, Panebianco V.
    Eur Radiol; 2019 Oct 18; 29(10):5498-5506. PubMed ID: 30887202
    [Abstract] [Full Text] [Related]

  • 8. The role of ultrasound in primary workup of cervical cancer staging (ESGO, ESTRO, ESP cervical cancer guidelines).
    Fischerová D, Cibula D.
    Ceska Gynekol; 2019 Oct 18; 84(1):40-48. PubMed ID: 31213057
    [Abstract] [Full Text] [Related]

  • 9. Preoperative lymph-node staging of invasive urothelial bladder cancer with 18F-fluorodeoxyglucose positron emission tomography/computed axial tomography and magnetic resonance imaging: correlation with histopathology.
    Jensen TK, Holt P, Gerke O, Riehmann M, Svolgaard B, Marcussen N, Bouchelouche K.
    Scand J Urol Nephrol; 2011 Mar 18; 45(2):122-8. PubMed ID: 21231796
    [Abstract] [Full Text] [Related]

  • 10. Imaging of Bladder Cancer: Standard Applications and Future Trends.
    Abouelkheir RT, Abdelhamid A, Abou El-Ghar M, El-Diasty T.
    Medicina (Kaunas); 2021 Mar 01; 57(3):. PubMed ID: 33804350
    [Abstract] [Full Text] [Related]

  • 11. Prospective evaluation of MRI, ¹¹C-acetate PET/CT and contrast-enhanced CT for staging of bladder cancer.
    Vargas HA, Akin O, Schöder H, Olgac S, Dalbagni G, Hricak H, Bochner BH.
    Eur J Radiol; 2012 Dec 01; 81(12):4131-7. PubMed ID: 22858427
    [Abstract] [Full Text] [Related]

  • 12. Update on novel imaging techniques for the detection of lymph node metastases in bladder cancer.
    Salminen AP, Jambor I, Syvanen KT, Bostrom PJ.
    Minerva Urol Nefrol; 2016 Apr 01; 68(2):138-49. PubMed ID: 27271230
    [Abstract] [Full Text] [Related]

  • 13. Contemporary Staging for Muscle-Invasive Bladder Cancer: Accuracy and Limitations.
    Hensley PJ, Panebianco V, Pietzak E, Kutikov A, Vikram R, Galsky MD, Shariat SF, Roupret M, Kamat AM.
    Eur Urol Oncol; 2022 Aug 01; 5(4):403-411. PubMed ID: 35581143
    [Abstract] [Full Text] [Related]

  • 14. Impact of 3T multiparametric MRI and FDG-PET-CT in the evaluation of occult primary cancer with cervical node metastasis.
    Gődény M, Lengyel Z, Polony G, Nagy ZT, Léránt G, Zámbó O, Remenár É, Tamás L, Kásler M.
    Cancer Imaging; 2016 Nov 04; 16(1):38. PubMed ID: 27814768
    [Abstract] [Full Text] [Related]

  • 15. Comparative sensitivity and specificity of imaging modalities in staging bladder cancer prior to radical cystectomy: a systematic review and meta-analysis.
    Crozier J, Papa N, Perera M, Ngo B, Bolton D, Sengupta S, Lawrentschuk N.
    World J Urol; 2019 Apr 04; 37(4):667-690. PubMed ID: 30120501
    [Abstract] [Full Text] [Related]

  • 16. ACR Appropriateness Criteria® Pretreatment Staging of Muscle-Invasive Bladder Cancer.
    Expert Panel on Urologic Imaging:, van der Pol CB, Sahni VA, Eberhardt SC, Oto A, Akin O, Alexander LF, Allen BC, Coakley FV, Froemming AT, Fulgham PF, Hosseinzadeh K, Maranchie JK, Mody RN, Schieda N, Schuster DM, Venkatesan AM, Wang CL, Lockhart ME.
    J Am Coll Radiol; 2018 May 04; 15(5S):S150-S159. PubMed ID: 29724418
    [Abstract] [Full Text] [Related]

  • 17. More advantages in detecting bone and soft tissue metastases from prostate cancer using 18F-PSMA PET/CT.
    Pianou NK, Stavrou PZ, Vlontzou E, Rondogianni P, Exarhos DN, Datseris IE.
    Hell J Nucl Med; 2019 May 04; 22(1):6-9. PubMed ID: 30843003
    [Abstract] [Full Text] [Related]

  • 18. Bladder cancer local staging: multiparametric MRI performance following transurethral resection.
    van der Pol CB, Shinagare AB, Tirumani SH, Preston MA, Vangel MG, Silverman SG.
    Abdom Radiol (NY); 2018 Sep 04; 43(9):2412-2423. PubMed ID: 29313114
    [Abstract] [Full Text] [Related]

  • 19. A two-way comparison of whole-body 18FDG PET-CT and whole-body contrast-enhanced MRI for distant metastasis staging in patients with malignant tumors: a meta-analysis of 13 prospective studies.
    Li J, Zhou H, Zhang X, Song F, Pang X, Wei Z.
    Ann Palliat Med; 2020 Mar 04; 9(2):247-255. PubMed ID: 32233618
    [Abstract] [Full Text] [Related]

  • 20. Comparing an Imaging-guided Pathway with the Standard Pathway for Staging Muscle-invasive Bladder Cancer: Preliminary Data from the BladderPath Study.
    Bryan RT, Liu W, Pirrie SJ, Amir R, Gallagher J, Hughes AI, Jefferson KP, Knight A, Nanton V, Mintz HP, Pope AM, Catto JWF, Patel P, James ND.
    Eur Urol; 2021 Jul 04; 80(1):12-15. PubMed ID: 33653635
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.